In this role, he is heading the Site Leadership Team in Laupheim and is part of the Global Leadership Team.
At the Laupheim site, Dr Stempfer is responsible for continuously identifying opportunities for improvement, reliably ensuring the development and production of complex biopharmaceuticals for clients and implementing innovative changes at the site in co-ordination with the Extended Executive Team.
He reports to Chief Operating Officer (COO) Christiane Bardroff.
Christiane Bardroff, COO of Rentschler Biopharma, said: “The appointment of Günter Stempfer as Site Head for Laupheim is an optimal solution. He has a deep knowledge of this production site and a proven track record of working effectively and successfully with the local team."
"With Günter Stempfer’s strong leadership and exceptional capabilities, we will ensure operational excellence at our headquarter’s site, in the interest of sustainability and patient care”.
Dr Stempfer joined Rentschler Biopharma on 1 January 2022, as Head of Global Strategic Development. Prior to that, he had advised the company in the area of production and led daily operations at the Laupheim site in close collaboration with the Company Leadership Team since the summer of 2021.
Dr Stempfer brings more than 25 years of experience in the biopharmaceutical industry. He has held various leadership positions, including Site Head at Sandoz in Kundl, Austria; Project Director at Novartis in Huningue, France; and Director Global TechOps at Polpharma in Poland, and is a recognized expert in development and production.
"Throughout my various roles at Rentschler Biopharma, my primary objective has always remained the same: the efficient, accurate, and timely delivery, also for complex development and production tasks, to enable our clients to provide effective medicines for seriously ill patients."
"The highly competent team in Laupheim shares this same commitment, and I look forward to our continued collaboration. At the same time, I will utilize my strong ties to our Stevenage and Milford sites to further strengthen collaboration and exchange across sites," Dr Günter Stempfer commented.
